Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | MYGN | Common Stock | Award | $0 | +15.2K | +44.59% | $0.00 | 49.1K | Jun 1, 2023 | Direct | F1 |
transaction | MYGN | Common Stock | Sale | -$199K | -8.64K | -17.58% | $23.01 | 40.5K | Jun 2, 2023 | Direct | F2 |
Id | Content |
---|---|
F1 | Consists of restricted stock units granted pursuant to Myriad Genetics, Inc.'s 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of common stock and vests upon the earlier of (a) the first anniversary of the date of grant and (b) the date of the next annual meeting of stockholders following such grant. |
F2 | The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan. |
Exhibit List: Exhibit 24 - Power of Attorney